Discover 3,601 paid clinical trials in Long Beach, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,601
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Location: Fountain Valley CA, Orange CA, Irvine CA, La Jolla CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07431281
Phase 3, Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
for
Osteoarthritis, Overweight or Obesity
Location: Fountain Valley CA, Santa Ana CA, Spring Valley CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07353931
Phase 3, Recruiting
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
for
Advanced Breast Cancer
Location: Fountain Valley CA, Los Angeles CA, Newport Beach CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06380751
Phase 3, Recruiting
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
for
Platinum-resistant Ovarian Cancer
Location: El Segundo CA, Newport Beach CA
Sponsor: ImmunityBio, Inc.
Sex: Female
Age: 18 - 70+
Code: NCT06710288
Phase 2, Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Location: Los Angeles CA, Upland CA, Scottsdale AZ, Tucson AZ,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05878717
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
GEMINI-NSCLC: NSCLC Biomarker Study
for
Non-Small Cell Lung Cancer
Location: Fountain Valley CA, Los Angeles CA, Las Vegas NV,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05236114
Recruiting
Stool Sample Collection Study
for
Colorectal Cancer
Location: Anaheim CA, Cordova TN, Ocala FL
Sponsor: Innovis LLC
Sex: All
Age: 18+
Code: NCT06294873
Recruiting
Randomized Withdrawal Study in Patients With Schizophrenia
for
Schizophrenia
Location: Pico Rivera CA, Costa Mesa CA, Oceanside CA,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT06961968
Phase 3, Recruiting
Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis
for
Primary Myelofibrosis (PMF),
Location: Whittier CA, Glendale CA, Houston TX, Canton OH
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04878003
Phase 2, Recruiting
ConsideRAte Study - Splenic Stimulation for RA
for
Rheumatoid Arthritis
Location: Whittier CA, Covina CA, Portland OR, Austin TX,
Sponsor: Galvani Bioelectronics
Sex: All
Age: 22 - 70+
Code: NCT05003310
Recruiting
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
for
Metastatic Pancreatic Adenocarcinoma
Location: Whittier CA, Canton OH, Tampa FL
Sponsor: Eleison Pharmaceuticals LLC.
Sex: All
Age: 18+
Code: NCT01954992
Phase 3, Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
for
Systemic Sclerosis
Location: Whittier CA, San Diego CA, Calgary, Austin TX,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07497087
Phase 3, Recruiting
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
for
Lymphoid Malignancies
Location: Whittier CA, Los Angeles CA, Duarte CA, Dallas TX,
Sponsor: AVM Biotechnology Inc
Sex: All
Age: 12 - 70+
Code: NCT04329728
Phase 1, Phase 2, Recruiting
PREDICT Therapy Selection for JAK, T-cell, or IL-6 Inhibitor Therapies Using a Molecular Signature Response Classifier (PREDICT)
for
Rheumatoid Arthritis
Location: Whittier CA
Sponsor: Scipher Medicine
Sex: All
Age: 18 - 70+
Code: NCT06390709
Recruiting
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
for
Cancer
Location: Whittier CA, Reno NV, Spokane WA, Springfield MO,
Sponsor: Tempus AI
Sex: All
Age: 18 - 70+
Code: NCT06207032
Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: Whittier CA, Fullerton CA, Santa Monica CA, Irvine CA,
Sponsor: Greenwich LifeSciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05232916
Phase 3, Recruiting
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
for
Breast Cancer, TNBC - Triple-Negative Breast Cancer,
Location: Whittier CA, Reno NV, Spokane Valley WA, Sioux Falls SD,
Sponsor: Tempus AI
Sex: All
Age: 18 - 70+
Code: NCT07211178
Recruiting
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
for
CLL, Chronic Lymphocytic Leukemia, SLL
Location: Whittier CA, Los Angeles CA, San Diego CA, Eugene OR,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06846671
Phase 3, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Downey CA, Newport Beach CA, Los Angeles CA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
for
Recurrent or Metastatic Solid Tumors
Location: Whittier CA, Los Angeles CA, Salt Lake City UT,